Table 6 Variables used to generate the propensity score
From: Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort study
Age (years) |
Sex |
Smoking status |
Body mass index (kg/m2) |
Cardiovascular disease diagnosis |
Ischemic heart disease diagnosis |
Hypertension diagnosis |
Components of the Charlson comorbidity index, diagnoses of: |
Myocardial infarction |
Stroke |
Heart failure |
Connective tissue disorders |
Dementia |
Diabetes |
Mild liver disease |
Peptic ulcer |
Peripheral vascular disease |
Pulmonary disease |
Cancer |
Paraplegia |
Other chronic respiratory diseases |
Number of prescriptions (categorized): |
Nasal corticosteroids |
Antibiotics prescribed on the same day as a lower respiratory consultation (identified by a Read code for a lower respiratory event) |
Acute oral corticosteroids (OCS) |
All OCS |
Short-acting muscarinic antagonists (SAMA) |
Medication ≥ 1 prescriptions (yes/no): |
Maintenance OCS |
Long-acting β-agonists (LABA) |
Long-acting muscarinic antagonists (LAMA) |
Methylxanthines |
Leukotriene receptor antagonists |
Short-acting β-agonists (SABA), mean daily dose (salbutamol equivalents), categorized |
Number of (categorized): |
Exacerbations (moderate/severe) |
Emergency department respiratory attendances |
Inpatient respiratory admissions |
Outpatient respiratory visits |